Higher frequency of peripheral blood interleukin 21 positive follicular helper T cells in patients with ankylosing spondylitis

Journal of Rheumatology

Volumn 40, Issue 12, 2013, Pages 2029-2037

  Xiao, Fei ^a   Zhang, Hai Yu ^a   Liu, Yi Jun ^a   Zhao, Ding ^a   Shan, Yu Xing ^a   Jiang, Yan Fang ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Ankylosing spondylitis; Disease activity; Follicular helper T cells; Interleukin 21; Therapeutic response

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CXCR5; ETANERCEPT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 21; MELOXICAM; PROGRAMMED DEATH 1 RECEPTOR; THALIDOMIDE;

ADOLESCENT; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE FUNCTION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; YOUNG ADULT;

ANKYLOSING SPONDYLITIS; DISEASE ACTIVITY; FOLLICULAR HELPER T CELLS; INTERLEUKIN 21; THERAPEUTIC RESPONSE;

ADOLESCENT; ADULT; FEMALE; FLOW CYTOMETRY; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INTERLEUKINS; MALE; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, CXCR5; SPONDYLITIS, ANKYLOSING; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; YOUNG ADULT;

EID: 84889076453     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130125     Document Type: Article

References (49)

1. Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH. Prevalence of rheumatic disease in Taiwan: a population-based study of urban, suburban, and rural differences. J Rheumatol 1994;21:302-6.
2. Brown MA. Genetics and the pathogenesis of ankylosing spondylitis. Curr Opin Rheumatol 2009;21:318-23.
3. Bowness P, Ridley A, Shaw J, Chan AT, Wong-Baeza I, Fleming M, et al. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in Ankylosing Spondylitis. Immunol 2011;186:2672-80.
4. Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011;43:761-7.
5. Mamedov IZ, Britanova OV, Chkalina AV, Staroverov DB, Amosova AL, Mishin AS, et al. Individual characterization of stably expanded T cell clones in ankylosing spondylitis patients. Autoimmunity 2009;42:525-6.
6. Cañete JD, Martínez SE, Farrés J, Sanmartí R, Blay M, Gómez A, et al. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis 2000;59:263-8.
7. Gratacós J, Collado A, Filella X, Sanmartí R, Cañete J, Llena J, et al. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994;33:927-31.
8. Claudepierre P, Rymer J-C, Chevalier X. IL-10 plasma levels correlate with disease activity in spondyloarthropathy. J Rheumatol 1997;24:1659-61.
9. Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009;60:1647-56.
10. Wu Y, Ren M, Yang R, Liang X, Ma Y, Tang Y, et al. Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther 2011;13:21-9.
11. Lin Q, Gu JR, Li TW, Zhang FC, Lin ZM, Liao ZT, et al. Value of the peripheral blood B-cells subsets in patients with ankylosing spondylitis. J Chin Med 2009;122:1784-9.
12. Wright C, Sibani S, Trudgian D, Fischer R, Kessler B, Labaer J, et al. Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. Mol Cell Proteom 2012;11:1-10.
13. Voswinkel J, Weisgerber K, Pfreundschuh M, Gause A. B-cell involvement in ankylosing spondylitis: the heavy chain variable segment gene repertoire of B-cells from germinal center-like foci in the synovial membrane indicates antigen selection. Arthritis Res 2001;3:189-95.
14. Song IH, Heldmann F, Rudwaleit M, Listing J, Appel H, Braun J, et al. Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed. Arthritis Rheum 2010;62:1290-7.
15. Yusuf I, Kageyama R, Monticelli L, Johnston RJ, Ditoro D, Hansen K, et al. Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150). Immunol 2010;185:190-202.
16. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, et al. Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011;34:108-21.
17. Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS, Ma L, et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008;29:138-49.
18. Kerfoot SM, Yaari G, Patel JR, Johnson KL, Gonzalez DG, Kleinstein SH, et al. Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone. Immunity 2011;34:947-60.
19. Linterman MA, Vinuesa CG. Signals that influence T follicular helper cell differentiation and function. Semin Immunopathol 2010;32:183-96.
20. Deenick EK, Ma CS. The regulation and role of T follicular helper cells in immunity. J Immunol 2011;134:361-7.
21. Ma J, Zhu C, Ma B, Tian J, Baidoo SE, Mao C, et al. Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin Dev Immunol 2012;10:1-7.
22. Rasmussen TK, Andersen T, Hvid M, Hetland ML, Hørslev-Petersen K, Stengaard-Pedersen K, et al. Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. J Rheumatol 2010;37:2014-20.
23. Linterman MA, Rigby RJ, Wong RK, Yu D, Brink R, Cannons JL, et al. Follicular helper T cells are required for systemic autoimmunity. J Exp Med 2009;206:561-76.
24. Simpson N, Gatenby PA, Wilson A, Malik S, Fulcher DA, Tangye SG, et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum 2010;62:234-44.
25. Sawalha AH, Kaufman KM, Kelly JA, Adler AJ, Aberle T, Kilpatrick J, et al. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann Rheum Dis 2008;67:458-61.
26. Li XY, Wu ZB, Ding J, Zheng ZH, Li XY, Chen LN, et al. Role of the frequency of blood CD4+ CXCR5+ CCR6+ T cells in autoimmunity in patients with Sjögren's syndrome. Biochem Biophys Res Commun 2012;422:238-44.
27. Vander Linden SM, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
28. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
29. Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 2001;44:1876-86.
30. Chou SJ, Lai NS, Su JP, Wu JL, Lan JL. Two color analysis of HLA-B27 antigen by flow cytometer - A comparative study by conventional microlymphocytoxicity, DNA genotyping polymerase chain reaction and flow cytometric measurement. J Clin Lab Analysis 1997;11:369-73.
31. Jiang Y, Ma Z, Xin G, Yan H, Li W, Xu H, et al. Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil. Mediators Inflamm 2010; 2010:143026.
32. McHeyzer-Williams LJ, Pelletier N, Mark L, Fazilleau N, McHeyzer-Williams MG. Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol 2009;21:266-73.
33. Linterman MA, Vinuesa CG. T follicular helper cells during immunity and tolerance. Prog Mol Biol Transl Sci 2010;92:207-48.
34. Dong C, Nurieva RI. Regulation of immune and autoimmune responses by ICOS. Autoimmun 2003;21:255-60.
35. Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, Hill KM, et al. A RING type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005;435:452-8.
36. Linterman MA, Rigby RJ, Wong R, Silva D, Withers D, Anderson G, et al. Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS. Immunity 2009;30:228-41.
37. Bauquet AT, Jin H, Paterson AM, Mitsdoerffer M, Ho IC, Sharpe AH, et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat Immunol 2009;10:167-75.
38. Hiramatsu Y, Suto A, Kashiwakuma D, Kanari H, Kagami S, Ikeda K, et al. c-Maf activates the promoter and enhancer of the IL-21 gene, and TGF-beta inhibits c-Maf-induced IL-21 production in CD4+ T cells. Leukoc Biol 2010;87:703-12.
39. Ettinger R, Kuchen S, Lipsky PE. The role of IL-21 in regulating B-cell function in health and disease. Immunol Rev 2008;223:60-86.
40. Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, Qi CF, et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 2004;173:5361-71.
41. Bryant VL, Ma CS, Avery DT, Li Y, Good KL, Corcoran LM, et al. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cell. J Immunol 2007;179:8180-90.
42. Wang CH, Hillsamer P, Kim CH. Phenotype, effector function, and tissue localization of PD-1-expressing human follicular helper T cell subsets. BMC Immunol 2011;12:1-15.
43. Andersen T, Rasmussen TK, Hvid M, Holm CK, Madsen KJ, Jurik AG, et al. Increased plasma levels of IL-21 and IL-23 in spondyloarthritis are not associated with clinical and MRI findings. Int J Rheumatol 2012;32:387-93.
44. Riley JL, June CH. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 2005;105:13-21.
45. Huang CH, Wong RH, Wei JC, Tsay MD, Chen WC, Chen HY, et al. Effects of genetic polymorphisms of programmed cell death 1 and its ligands on the development of ankylosing spondylitis. Rheumatology 2011;50:1809-13.
46. Wan B, Nie H, Liu A, Feng G, He D, Xu R, et al. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J Immunol 2006;177:8844-50.
47. Kobayashi M, Kawano S, Hatachi S, Kurimoto C, Okazaki T, Iwai Y, et al. Enhanced expression of programmed death-1(PD-1)/PD-L1 in salivary glands of patients with Sjogren's syndrome. J Rheumatol 2005;32:2156-63.
48. Wolf J, Fasching P. Ankylosing spondylitis. Wien Med Wochenschr 2010;160:211-4.
49. Liu CQ, Xia XZ, Wu W, Wu R, Tang M, Chen T, et al. Anti-TNF therapy enhances mucosal healing through downregulation of IL-21 expression and Th17 cell infiltration in Crohn's disease. Clin Exp Immunol 2013;73:102-11.